SELLAS Life Sciences Group, Inc. (SLS) has a market capitalization of $692.27M and trades at $4.86. The 52-week range is 0.95-6.14.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -19.4, Earnings Per Share (EPS) of $-0.25.
The stock has a beta of 2.23, operates in the Healthcare sector.
